In CML and Ph-ALL, induction of SET expression is controlled by BCR/ABL (82), while in AML, overexpression of EVl1 or downregulation of miR199b may contribute (134). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.